An employee of the German biopharmaceutical company CureVac, demonstrates research into a vaccine for coronavirus (COVID-19) at a laboratory in Tuebingen, Germany, March 12, 2020. Andreas Gebert | REUTERS CureVac raised $ 213 million in its initial public offering (IPO) in New York on Thursday, said a person familiar with …
Read More »Coronavirus vaccine developer CureVac raises $ 213 million in IPO
